Search

Cogent Biosciences Inc

Fechado

38.8 -6.48

Visão Geral

Variação de preço das ações

24h

Atual

Mín

38.67

Máximo

39.32

Indicadores-chave

By Trading Economics

Rendimento

5.1M

-97M

EPS

-0.53

Funcionários

258

EBITDA

14M

-95M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+34.68% upside

Dividendos

By Acuity

Próximos Ganhos

4 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

636M

6.9B

Abertura anterior

45.28

Fecho anterior

38.8

Cogent Biosciences Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

1 de ago. de 2026, 23:51 UTC

Correlated Moves

Bitcoin is trading lower, reflecting a cumulative decline since Friday. The asset is approximately 2.53% below its 20-day moving average.

1 de ago. de 2026, 23:01 UTC

The Nikkei 225 Index is trading lower during after-market hours, reflecting a decline from earlier highs and remaining near the lower end of its one-month range.

1 de ago. de 2026, 20:01 UTC

Oil (Brent) is trading higher in after-market hours, reflecting strong momentum and remaining above its 20-day moving average. No specific news was identified.

1 de ago. de 2026, 20:01 UTC

Correlated Moves

Silver is trading lower in after-market hours, reflecting weakness since Friday's close. The price is near the lower end of its one-month range.

1 de ago. de 2026, 20:01 UTC

The DAX 30 Index is trading lower in after-market hours, reversing earlier gains and closing below Friday's level. No specific news was identified.

1 de ago. de 2026, 20:01 UTC

Correlated Moves

Gold prices are lower during after-market hours, reflecting unusual price action near the lower end of its one-month range. Silver also declined in tandem.

1 de ago. de 2026, 19:11 UTC

Correlated Moves

Avalanche is trading lower during Saturday's session amid a broader cryptocurrency market downturn, with Bitcoin also declining and the asset below its 20-day moving average.

1 de ago. de 2026, 19:01 UTC

News
Correlated Moves

Ethereum is trading lower, reflecting a broader decline in correlated assets. It remains below its 20-day moving average amid routine market fluctuations.

1 de ago. de 2026, 18:51 UTC

Cardano is trading higher during Saturday's session, reflecting a cumulative gain since Friday. The asset remains above its 20-day moving average.

1 de ago. de 2026, 18:41 UTC

Correlated Moves

Ethereum is trading lower today, influenced by declines in Bitcoin. The asset remains near the upper end of its one-month range.

1 de ago. de 2026, 18:01 UTC

The Nasdaq 100 Index is lower during after-market hours, declining since Friday's close and trading near the lower end of its one-month range.

1 de ago. de 2026, 11:52 UTC

Fed Chair Kevin Warsh's Upcoming Speech Sparks Market Speculation on Interest Rate Changes Amid Rising Inflation Concerns.

1 de ago. de 2026, 11:52 UTC

U.S. Nonfarm Productivity Expected to Rise 0.7% in Q2 2026 Amid Mixed Economic Signals

1 de ago. de 2026, 11:52 UTC

U.S. Unit Labour Costs Set to Rise 2.7% Amid Strong Wage Growth, Heightening Inflation Concerns Ahead of Federal Reserve Policy Decisions

1 de ago. de 2026, 11:51 UTC

Swiss markets closed for National Day; Bitcoin and Ethereum see slight gains, while concerns grow over U.S. stock market reliance on AI-driven stocks and potential Japanese Yen interventions.

1 de ago. de 2026, 11:51 UTC

"Bitcoin and Ethereum see gains amid speculation, while U.S. Dollar dips as traders eye key economic data and potential Fed policy shifts."

1 de ago. de 2026, 11:51 UTC

Bitcoin and Ethereum see modest gains amid economic uncertainties, while U.S. stock market concentration raises investor concerns and key labor data looms ahead.

1 de ago. de 2026, 11:51 UTC

Swiss markets closed for National Day; U.S. stocks rally amid inflation concerns and upcoming key labor data.

1 de ago. de 2026, 11:41 UTC

Mexico's Inflation Rate Release on August 7, 2026 Expected to Show Continued Easing Amid Global Trends.

1 de ago. de 2026, 11:41 UTC

U.S. Mortgage Rates Hit One-Year High at 6.66%, Raising Concerns Over Homebuying Demand Ahead of MBA Release on August 5

1 de ago. de 2026, 11:41 UTC

Mexico's Inflation Rate Release on August 7, 2026: Market Anticipates Impact on Economic Policy Amid Mixed Sentiment and External Risks.

1 de ago. de 2026, 11:31 UTC

U.S. Exports Data Release on August 4, 2026, Sparks Caution Amid Economic Slowdown and Global Trade Tensions

1 de ago. de 2026, 11:31 UTC

U.S. Trade Deficit Expected to Widen to -$73 Billion Amid Rising Imports and Geopolitical Tensions

1 de ago. de 2026, 11:22 UTC

U.S. Imports Data Release on August 4 Expected to Show Continued Growth Amid Tariff Distortions and Global Trade Dynamics

1 de ago. de 2026, 11:22 UTC

Canada's Balance of Trade expected to show C$3.0 billion surplus amid mixed economic sentiment and external challenges on August 4, 2026.

1 de ago. de 2026, 11:22 UTC

Market anticipates 75K job increase in upcoming ADP Employment Change report amid mixed economic signals and cautious optimism.

1 de ago. de 2026, 11:02 UTC

Japan's Upcoming Household Spending Report Signals Consumer Caution Amid Mixed Economic Indicators and Retail Disappointment.

1 de ago. de 2026, 11:02 UTC

Japan's Household Spending Expected to Rise 0.9% Amid Inflation Concerns and Yen Volatility Ahead of August Release

1 de ago. de 2026, 10:51 UTC

Brazil's Central Bank Faces Pressure on SELIC Rate Decision Amid Inflation and Economic Stability Concerns Ahead of August 5th Announcement.

1 de ago. de 2026, 10:51 UTC

Mexican Consumer Confidence Index Set for Release Amid Cautious Optimism and Mixed Economic Sentiment on August 4, 2026.

Comparação entre Pares

Variação de preço

Cogent Biosciences Inc Previsão

Preço-alvo

By TipRanks

34.68% parte superior

Previsão para 12 meses

Média 52.43 USD  34.68%

Máximo 60 USD

Mínimo 45 USD

Com base em 9 analistas de Wall Street que oferecem metas de preço de 12 meses para Cogent Biosciences Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

9 ratings

8

Comprar

1

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Cogent Biosciences Inc

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
help-icon Live chat